Dove Medical Press
Dove Medical Press is a publisher specializing in open access, peer-reviewed scientific and medical journals. It has offices located in Macclesfield and London in the UK, Princeton in the US, and Auckland in New Zealand. In September 2017, Dove Medical Press became part of the Taylor and Francis Group. As an open access publisher, Dove Medical Press requires a publication fee from authors, their institutions, or funding bodies. This fee helps cover the costs of editorial work and production, and it also contributes to a fund that provides fee waivers for authors from developing countries. The published articles can be accessed through an interface that complies with the Open Archives Initiative Protocol for Metadata Harvesting, which establishes consistent standards for managing archive metadata.
Outlet metrics
Global
#78417
United States
#70535
Health/Health
#1517
Articles
-
2 weeks ago |
dovepress.com | Qin Wang |Lei Wang |Li Zhang |Chongyang Zhao
Qin Wang,1,2,* Lei Wang,2,* Li Zhang,2 Chongyang Zhao,1 Ying Liu,2 Lei Liu,2 Lishan Yuan,2 Min Feng,3,4 Gang Wang,5 Li Li,1 Shuwen Zhang,6 Yulai Yuan,7 Deying Kang,1,8 Xin Zhang2 1Department of Evidence-Based Medicine and Clinical Epidemiology, West China Hospital, Sichuan University, Chengdu, People’s Republic of China; 2Division of Internal Medicine, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, People’s Republic...
-
1 month ago |
dovepress.com | Xiaoqing Lin |Ziwei Zhang |TaoHu Zhou |Jie Li
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 20 Authors Lin X, Zhang Z , Zhou T, Li J, Jin Q, Li Y, Guan Y , Xia Y, Zhou X, Fan L Received 26 November 2024 Accepted for publication 25 April 2025 Published 6 May 2025 Volume 2025:20 Pages 1395—1406 DOI https://doi.org/10.2147/COPD.S508775 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Jill Ohar Xiaoqing Lin,1,2,*...
-
2 months ago |
dovepress.com
Reporting the efficacy of aflibercept (8 mg) for diabetic macular edema (DME) in vitrectomized eyes refractory to other anti-VEGF drug therapies.
-
2 months ago |
dovepress.com | Preeya K. Gupta |Vance Thompson |Leslie O’dell |Anh Ho
Preeya K Gupta,1 Vance Thompson,2 Leslie O’Dell,2 Anh N Ho,3 Arthur Chan,3 Bhagyashree Oak,4 Amod Athavale,4 Elizabeth Yeu3 1Triangle Eye Consultants, Raleigh, NC, USA; 2Vance Thompson Vision, Sioux Falls, SD, USA; 3Tarsus Pharmaceuticals, Inc, Irvine, CA, USA; 4Trinity Life Sciences, Waltham, MA, USA Correspondence: Amod Athavale, Trinity Life Sciences, 230 3rd Ave, Waltham, MA, 02451, USA, Email [email protected] Background: Demodex blepharitis is an ocular disorder caused by the...
-
Jan 20, 2025 |
dovepress.com | Angela Burge |Narelle S. Cox |Simone Dal Corso |Arwel W Jones
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 20 Authors Burge AT , Cox NS , Dal Corso S, Jones AW , Faqih FM, Holland AE Received 15 August 2024 Accepted for publication 19 November 2024 Published 20 January 2025 Volume 2025:20 Pages 149—158 DOI https://doi.org/10.2147/COPD.S491654 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Richard Russell Angela T Burge,1,2...
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Contact Forms
Contact Form
Website
http://dovepress.com/Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →